ID   COG-N-453
AC   CVCL_LF59
DR   cancercelllines; CVCL_LF59
DR   GEO; GSM2371226
DR   GEO; GSM4104575
DR   GEO; GSM4104576
DR   Wikidata; Q54814027
RX   PubMed=28350380;
CC   Doubling time: 71 hours (COG).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (PubMed=28350380).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 15,17
ST   D19S433: 12
ST   D21S11: 29
ST   D2S1338: 18,23
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 18,22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS96 ! COG-N-452
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
RX   PubMed=28350380; DOI=10.1038/sdata.2017.33; PMCID=PMC5369315;
RA   Harenza J.L., Diamond M.A., Adams R.N., Song M.M., Davidson H.L.,
RA   Hart L.S., Dent M.H., Fortina P., Reynolds C.P., Maris J.M.;
RT   "Transcriptomic profiling of 39 commonly-used neuroblastoma cell
RT   lines.";
RL   Sci. Data 4:170033.1-170033.8(2017).
//